Intrinsic Value of S&P & Nasdaq Contact Us

Viatris Inc. VTRS NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
38/100
1/7 Pass
SharesGrow Intrinsic Value
$52.56
+277.9%
Analyst Price Target
$15.25
+9.6%

Stock Statistics — VTRS

Viatris Inc. (VTRS) has a market capitalization of $16.02B and trades at $13.91. The 52-week range is 6.85-16.47.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -4.6, Earnings Per Share (EPS) of $-3.00, annual revenue of $14.3B.

The stock has a beta of 0.82, a last dividend of $0.4800, operates in the Healthcare sector.

Trading Data
Current Price$13.91
52-Week Range6.85-16.47
Volume6.13M
Avg Volume (30D)10.09M
Market Cap$16.02B
Beta (1Y)0.82
Last Dividend$0.4800
Company
IPO Date1980-03-17
Employees32,000
CEOScott Andrew Smith
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS92556V1061
CUSIP92556V106
Income (Latest Year)
Revenue$14.3B
Gross Profit$5.01B
EBITDA$-395.4M
Operating Income$-2.66B
Net Income$-3.51B
EPS$-3.00
EPS Diluted$-3.00
Shares Outstanding$1.17B
Balance Sheet (Latest Year)
Total Assets$37.19B
Current Assets$9.22B
Cash & ST Investments$1.45B
Total Liabilities$22.48B
Total Debt$14.7B
Net Debt$13.35B
Total Equity$14.71B
Debt / Equity1.00
Valuation Ratios
P/E Ratio-4.6
P/S Ratio1.12
P/B Ratio1.09
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message